FDA
FDA biologics chief Vinay Prasad to leave agency at end of April
Сообщено ИИ Изображение, созданное ИИ Проверено фактами
Dr. Vinay Prasad, who leads the FDA division that oversees vaccines and other biological products, will leave the agency at the end of April, FDA Commissioner Marty Makary told staff in an email. It will be Prasad’s second departure in less than a year after a brief exit last summer amid clashes over high-profile drug and vaccine reviews.
Inovio Pharmaceuticals held its first-quarter 2026 earnings call on May 13 to discuss financial results for the period ended March 31 and provide updates on its DNA medicines platform.
Сообщено ИИ
Syntara Limited held a shareholder webinar on April 29 to discuss FDA feedback on its proposed Phase IIb trial for amsulostat in myelofibrosis, along with a capital raise and quarterly report. CEO Gary Phillips highlighted the agreed path forward with regulators. The company lodged its Appendix 4C quarterly with the ASX.
The U.S. Senate has confirmed Robert Califf to lead the Food and Drug Administration amid ongoing public health challenges. Califf, a cardiologist with prior FDA experience, was approved in a bipartisan vote. This move aims to stabilize the agency during debates over drug approvals and regulations.
Сообщено ИИ
The U.S. Supreme Court unanimously ruled on June 13, 2024, that the FDA's approval of the abortion pill mifepristone is valid and remains in effect. The decision dismissed challenges from anti-abortion groups, affirming the agency's regulatory authority. This ruling ensures continued access to medication abortion, which accounts for more than half of U.S. abortions.
The FDA approved a new drug for treating autoimmune neuropathies on September 9, 2025, accompanied by discoveries of new autoantibodies and effective complement inhibitors. This development ends 30 years of limited treatment progress in the field.
Сообщено ИИ Проверено фактами
The US Food and Drug Administration granted clearance to Apple's new hypertension detection feature for the Apple Watch on September 11, 2025. The feature, announced at Apple's early September product launch, will be available in 150 countries starting next week.
FDA approves Travere Therapeutics' FILSPARI for FSGS
01 января 2026, 08:26US FDA approves first oral pill for thalassaemia anaemia
20 ноября 2025, 04:09Paradromics receives FDA approval for brain implant trial
12 ноября 2025, 22:22Poll, high‑profile cases fuel bipartisan push to revisit mail‑order abortion pill rules
11 ноября 2025, 09:36FDA removes black box warning from menopause hormone therapy
30 сентября 2025, 00:32FDA issues final rule on clinical trials diversity
26 сентября 2025, 00:23Coalition Opposes FDA's Proposed Ban on 7-OH Substance
22 сентября 2025, 00:09FDA Approves Injectable Form of Merck's Keytruda
20 сентября 2025, 00:15FDA Grants Accelerated Approval for First Barth Syndrome Treatment
15 сентября 2025, 00:23FDA Approves New Hypertension Detection Device